#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma pancreas Choroidal dystrophy Mantle cell lymphoma refractory Familial dilated cardiomyopathy Hereditary angioedema with C1 esterase inhibitor deficiency Oropharyngeal squamous cell carcinoma Toxic epidermal necrolysis Desmoid tumour Immune-mediated enterocolitis Cytomegalovirus infection Neurodermatitis Congenital generalised lipodystrophy Systemic sclerosis pulmonary Kearns-Sayre syndrome Antiphospholipid antibodies More trials…

    Learn about Rare Diseases

    Vascular malformation – Diagnostics Alexander disease – Trials in Disease Angelman’s syndrome – Basic Information Behcet’s syndrome – Treatment Splenic marginal zone lymphoma – Life with Disease Choroid melanoma – Basic Information Mantle cell lymphoma Optic glioma – Basic Information Anaplastic thyroid cancer – Trials in Disease Aicardi-Goutieres syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-PHENYLALANINE Duloxetine Bms-986458 Bgb-A445 Naloxegol Oxalate Doxorubicin Fampridine Triptorelin Fentanyl Citrate Imetelstat Sodium Lutetium (177Lu) Oxodotreotide TRIGLYCERIDES MEDIUM CHAIN Latozinemab IBANDRONIC ACID Bicalutamide Aup1602-C Anhydrous Cidofovir Epirubicin Naxitamab Casimersen More therapies…

    Learn about Your Condition

    Malformation venous Pain in extremity Dent's disease Cataract Pancreatitis relapsing Uterine leiomyoma Bone marrow disorder Gouty arthritis Combined immunodeficiency Aortic aneurysm Pertussis Rheumatic disorder Electrocorticogram Congenital myopathy Oedema peripheral More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study on Transmural Healing in Patients with Moderate to Severe Crohn’s Disease Using Upadacitinib and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Budesonide
    • Adalimumab
    Belgium Denmark France Germany Italy The Netherlands +2

  • Study on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Metastases to liver
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Floxuridine
    • Heparin
    • Bevacizumab
    The Netherlands

  • Study on the Safety of Continuing Apixaban, Clopidogrel, and Rivaroxaban During Polyp Removal in Patients on Antiplatelet or Anticoagulant Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acenocoumarol
    • Lactose Monohydrate
    • Telmisartan
    Spain

  • Study on the Long-term Safety of Guselkumab for Children with Crohn’s Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Guselkumab
    Belgium France Germany Italy Norway Poland +2

  • Study of personalized FOLFIRINOX drug combination dosing (fluorouracil, irinotecan, oxaliplatin, and calcium folinate) for patients with pancreatic cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Fluorouracil
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands
Previous Page
1 … 34 35 36 37 38 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!